Full year FY21 revenue was $212m for an EBITDA of $22.8m- assume so Covid related contractions here as well.
Assuming FY23 is $210m then can we assume a profit of around the same range? Nice for the Company to be in positive EBITDA range with the recent challenges.
This Ukraine contract is taking ages way beyond what the Company said the timelines were. I guess we are dealing with a country at war but hopefully a nice boost to FY24 earnings.
- Forums
- ASX - By Stock
- Ann: EOS expects 2023 revenue of $210m to $230m
Full year FY21 revenue was $212m for an EBITDA of $22.8m- assume...
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EOS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.60 |
Change
-0.055(3.33%) |
Mkt cap ! $307.7M |
Open | High | Low | Value | Volume |
$1.65 | $1.65 | $1.55 | $485.1K | 305.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 630 | $1.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.62 | 6000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 630 | 1.595 |
1 | 2048 | 1.590 |
1 | 2048 | 1.585 |
1 | 2048 | 1.580 |
1 | 2048 | 1.575 |
Price($) | Vol. | No. |
---|---|---|
1.615 | 6000 | 1 |
1.620 | 2048 | 2 |
1.625 | 2048 | 1 |
1.630 | 2048 | 1 |
1.635 | 2048 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.60 |
  |
Change
-0.055 ( 3.52 %) |
|||
Open | High | Low | Volume | ||
$1.64 | $1.65 | $1.55 | 34177 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
EOS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online